Cytokinetics Inc (CYTK)

EBITDA

-$821.80M

TTM · Period ending: · USD

CYTK logo

CYTK EBITDA

Latest reported-$821.80M
CYTK TTM EBITDA (-$47.62M → -$821.80M)
High-resolution chart · PNG

CYTK ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cytokinetics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-821,796,000
-734,485,000
-701,297,000
-646,170,000
-504,829,000
-513,622,000
-493,483,000
-481,937,000
-459,673,000
-456,475,000
-455,749,000
-461,705,000
-472,588,000
-367,776,000
-331,305,000
-233,199,000
-177,252,000
-222,716,000
-183,706,000
-196,149,000
-121,921,000
-98,414,000
-88,584,000
-76,779,000
-105,070,000
-99,902,000
-93,039,000
-91,613,000
-85,365,000
-81,642,000
-83,167,000
-97,771,000
-108,643,000
-111,117,000
-108,895,000
-70,320,000
-8,983,000
4,319,000
14,929,000
2,647,000
-40,237,000
-39,838,000
-36,818,000
-19,390,000
-16,520,000
-14,363,000
-14,264,000
-16,302,000
-22,940,000
-29,603,000
-33,461,000
-51,341,000
-48,766,000
-42,643,000
-39,867,000
-40,086,000
-40,528,000
-44,931,000
-46,458,000
-46,009,000
-47,665,000
-47,043,000
-47,400,000
-49,145,000
-44,707,000
27,652,000
29,213,000
31,492,000
25,486,000
-49,669,000
-54,150,000
-57,853,000
-56,782,000
-55,199,000
-53,657,000
-55,632,000
-58,377,000
-58,703,000
-58,411,000
-53,090,000
-47,784,000
-43,969,000
-41,572,000
-42,094,000
-41,954,000
-40,330,000
-35,159,000
-64,207,000
-51,734,000
-47,760,000
-47,618,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.